[en] OBJECTIVE: The LH/chorionic gonadotrophin receptor (LHCGR) is a G protein-coupled receptor (GPCR) that plays a central role in male sexual differentiation, regulation of ovarian follicular maturation, ovulation and maintenance of corpus luteum and pregnancy, as well as maintenance of testicular testosterone production. Mutations in the LHCGR gene are very rare. The aim of this work was to study the clinical and molecular characteristics of a rare familial LHCGR mutation. METHODS: Five affected members of a family, including a phenotypically female, but genotypically male (46,XY), patient with Leydig cell hypoplasia type 1 and four genotypically female siblings with reproductive abnormalities, were studied genetically. Cell trafficking studies as well as signalling studies of mutated receptor were performed. RESULTS: The five affected patients were all homozygous for a novel mutation in the LHCGR gene, a deletion of guanine in position 1850 (1850delG). This resulted in a frameshift affecting most of the C-terminal intracellular domain. In vitro studies demonstrated that the 1850delG receptor was completely incapable of transit to the cell membrane, becoming trapped within the endoplasmic reticulum. This could not be rescued by small-molecule agonist treatment or stimulated intracellularly by co-expression of a yoked human chorionic gonadotrophin. CONCLUSIONS: This novel LHCGR mutation leads to complete inactivation of the LHCGR receptor due to trafficking and signalling abnormalities, which improves our understanding of the impact of the affected structural domain on receptor trafficking and function.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Rivero-Muller, Adolfo
Potorac, Iulia ; Université de Liège - ULiège > CHU - @chu - AD
Pintiaux, Axelle ; Université de Liège > Département des sciences cliniques > Gynécologie - Obstétrique
Daly, Adrian ; Université de Liège > Département des sciences cliniques > Endocrinologie
THIRY, Albert ; Centre Hospitalier Universitaire de Liège - CHU > Anatomie pathologique
Rydlewski, Catherine
Nisolle, Michelle ; Université de Liège > Département des sciences cliniques > Gynécologie - Obstétrique
Parent, Anne-Simone ; Université de Liège > Département des sciences cliniques > Pédiatrie
Huhtaniemi, Ilpo
Beckers, Albert ; Université de Liège > Département des sciences cliniques > Endocrinologie
Language :
English
Title :
A novel inactivating mutation of the LH/chorionic gonadotrophin receptor with impaired membrane trafficking leading to Leydig cell hypoplasia type 1.
Themmen APN & Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocrine Reviews 2000 21 551-583. (doi:10.1210/edrv.21.5.0409).
Toledo SP, Brunner HG, Kraaij R, Post M, Dahia PL, Hayashida CY & Kremer HTAP. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46, XX female. Journal of Clinical Endocrinology and Metabolism 1996 81 3850-3854. (doi:10.1210/jcem. 81.11.8923827).
Latronico AC & Arnhold IJ. Inactivating mutations of LH and FSH receptors - from genotype to phenotype. Pediatric Endocrinology Reviews 2006 4 28-31.
Rivero-Muller A, Chou YY, Ji I, Lajic S, Hanyaloglu AC, Jonas K, Rahman N, Ji TH & Huhtaniemi I. Rescue of defective G proteincoupled receptor function in vivo by intermolecular cooperation. PNAS 2010 107 2319-2324. (doi:10.1073/pnas.0906695106).
Trehan A, Rotgers E, Coffey ET, Huhtaniemi I & Rivero-Muller A. CANDLES, an assay for monitoring GPCR induced cAMP generation in cell cultures. Cell Communication and Signaling 2014 12 70. (doi:10.1186/s12964-014-0070-x).
Peuhu E, Rivero-Muller A, Stykki H, Torvaldson E, Holmbom T, Eklund P, Unkila M, Sjoholm R & Eriksson JE. Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis. Oncogene 2010 29 898-908. (doi:10.1038/onc.2009.386).
Narayan P, Wu C & Puett D. Functional expression of yoked human chorionic gonadotropin in baculovirus-infected insect cells. Molecular Endocrinology 1995 9 1720-1726. (doi:10.1210/mend.9.12.8614408).
Newton CL, Whay AM, McArdle CA, Zhang M, van Koppen CJ, van de Lagemaat R, Segaloff DL & Millar RP. Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonist. PNAS 2011 108 7172-7176. (doi:10.1073/pnas.1015723108).
Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes and Development 1999 13 1211-1233. (doi:10.1101/gad. 13.10.1211).
Gromoll J, Eiholzer U, Nieschlag E & Simoni M. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. Journal of Clinical Endocrinology and Metabolism 2000 85 2281-2286. (doi:10.1210/jcem.85.6.6636).
Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley WF & Jameson JL. Hypogonadism caused by a single amino acid substitution in the b subunit of luteinizing hormone. New England Journal of Medicine 1992 326 179-183. (doi:10.1056/NEJM199201163260306).
Valdes-Socin H, Salvi R, Daly AF, Gaillard RC, Quatresooz P, Tebeu PM, Pralong FP & Beckers A. Hypogonadism in a patient with a mutation in the luteinizing hormone b-subunit gene. New England Journal of Medicine 2004 351 2619-2625. (doi:10.1056/NEJMoa040326).
Achard C, Courtillot C, Lahuna O, Meduri G, Soufir JC, Liere P, Bachelot A, Benyounes H, Schumacher M, Kuttenn F et al. Normal spermatogenesis in a man with mutant luteinizing hormone. New England Journal of Medicine 2009 361 1856-1863. (doi:10.1056/NEJMoa0805792).
Lofrano-Porto A, Barra GB, Giacomini LA, Nascimento PP, Latronico AC, Casulari LA & da Rocha Neves Fde A. Luteinizing hormone b mutation and hypogonadism in men and women. New England Journal of Medicine 2007 357 897-904. (doi:10.1056/NEJMoa071999).
Basciani S, Watanabe M, Mariani S, Passeri M, Persichetti A, Fiore D, Scotto d'Abusco A, Caprio M, Lenzi A, Fabbri A et al. Hypogonadism in a patient with two novel mutations of the luteinizing hormone b-subunit gene expressed in a compound heterozygous form. Journal of Clinical Endocrinology and Metabolism 2012 97 3031-3038. (doi:10.1210/jc. 2012-1986).
Latronico AC & Arnhold IJ. Gonadotropin resistance. Endocrine Development 2013 24 25-32. (doi:10.1159/000342496).
Hannema SE, Scott IS, Hodapp J, Martin H, Coleman N, Schwabe JW & Hughes IA. Residual activity of mutant androgen receptors explains wolffian duct development in the complete androgen insensitivity syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 5815-5822. (doi:10.1210/jc.2004-0709).
Kaprova-Pleskacova J, Stoop H, Bruggenwirth H, Cools M, Wolffenbuttel KP, Drop SL, Snajderova M, Lebl J, Oosterhuis JW & Looijenga LH. Complete androgen insensitivity syndrome: factors influencing gonadal histology including germ cell pathology. Modern Pathology 2014 27 721-730. (doi:10.1038/modpathol.2013.193).
Hannema SE, Scott IS, Rajpert-De Meyts E, Skakkebaek NE, Coleman N & Hughes IA. Testicular development in the complete androgen insensitivity syndrome. Journal of Pathology 2006 208 518-527. (doi:10.1002/path.1890).
Zhang FP, Poutanen M, Wilbertz J & Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Molecular Endocrinology 2001 15 172-183. (doi:10.1210/mend.15.1.0582).
Lei ZM, Mishra S, Zou W, Xu B, Foltz M, Li X & Rao CV. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Molecular Endocrinology 2001 15 184-200. (doi:10.1210/mend.15.1.0586).
Tepper MA & Roberts JL. Evidence for only one b-luteinizing hormone and no b-chorionic gonadotropin gene in the rat. Endocrinology 1984 115 385-391. (doi:10.1210/endo-115-1-385).
Carr FE & Chin WW. Absence of detectable chorionic gonadotropin subunit messenger ribonucleic acids in the rat placenta throughout gestation. Endocrinology 1985 116 1151-1157. (doi:10.1210/endo- 116-3-1151).
O'Shaughnessy PJ, Fleming LM, Jackson G, Hochgeschwender U, Reed P & Baker PJ. Adrenocorticotropic hormone directly stimulates testosterone production by the fetal and neonatal mouse testis. Endocrinology 2003 144 3279-3284. (doi:10.1210/en.2003-0277).
Zhang FP, Pakarainen T, Poutanen M, Toppari J & Huhtaniemi I. The low gonadotropin-independent constitutive production of testicular testosterone is sufficient to maintain spermatogenesis. PNAS 2003 100 13692-13697. (doi:10.1073/pnas.2232815100).
Xu C, Bailly-Maitre B & Reed JC. Endoplasmic reticulum stress: cell life and death decisions. Journal of Clinical Investigation 2005 115 2656-2664. (doi:10.1172/JCI26373).
Kremer H, Kraaij R, Toledo SP, Post M, Fridman JB, Hayashida CY, van Reen M, Milgrom E, Ropers HH, Mariman E et al. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nature Genetics 1995 9 160-164. (doi:10.1038/ng0295-160).
Latronico AC, Anasti J, Arnhold IJ, Rapaport R, Mendonca BB, Bloise W, Castro M, Tsigos C & Chrousos GP. Brief report: Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. New England Journal of Medicine 1996 334 507-512. (doi:10.1056/NEJM199602223340805).
Fredriksson R, Lagerstrom MC, Lundin LG & Schioth HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Molecular Pharmacology 2003 63 1256-1272. (doi:10.1124/mol.63.6. 1256).
Dong C, Filipeanu CM, Duvernay MT &Wu G. Regulation of G proteincoupled receptor export trafficking. Biochimica et Biophysica Acta 2007 1768 853-870. (doi:10.1016/j.bbamem.2006.09.008).
Findlay J & Eliopoulos E. Three-dimensional modelling of G protein-linked receptors. Trends in Pharmacological Sciences 1990 11 492-499. (doi:10.1016/0165-6147(90)90050-I).
Konvicka K, Guarnieri F, Ballesteros JA & Weinstein H. A proposed structure for transmembrane segment 7 of G protein-coupled receptors incorporating an asn-Pro/Asp-Pro motif. Biophysical Journal 1998 75 601-611. (doi:10.1016/S0006-3495(98)77551-4).
Rodriguez MC, Xie YB, Wang H, Collison K & Segaloff DL. Effects of truncations of the cytoplasmic tail of the luteinizing hormone/chorionic gonadotropin receptor on receptor-mediated hormone internalization. Molecular Endocrinology 1992 6 327-336. (doi:10.1210/mend.6.3.1316539).
Martens JW, Lumbroso S, Verhoef-Post M, Georget V, Richter-Unruh A, Szarras-Czapnik M, Romer TE, Brunner HG, Themmen AP & Sultan C. Mutant luteinizing hormone receptors in a compound heterozygous patient with complete Leydig cell hypoplasia: Abnormal processing causes signaling deficiency. Journal of Clinical Endocrinology and Metabolism 2002 87 2506-2513. (doi:10.1210/jcem.87.6.8523).
Laue L, Wu SM, Kudo M, Hsueh AJ, Cutler GB Jr, Griffin JE, Wilson JD, Brain C, Berry AC, Grant DB et al. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Human Molecular Genetics 1995 4 1429-1433. (doi:10.1093/hmg/4.8.1429).
Zhu H, Wang H & Ascoli M. The lutropin/choriogonadotropin receptor is palmitoylated at intracellular cysteine residues. Molecular Endocrinology 1995 9 141-150. (doi:10.1210/mend.9.2.7776964).
Kawate N & Menon KM. Palmitoylation of luteinizing hormone/human choriogonadotropin receptors in transfected cells. Abolition of palmitoylation by mutation of Cys-621 and Cys-622 residues in the cytoplasmic tail increases ligand-induced internalization of the receptor. Journal of Biological Chemistry 1994 269 30651-30658.
Barak LS, Menard L, Ferguson SS, Colapietro AM & Caron MG. The conserved seven-transmembrane sequence NP(X)2, 3Y of the G-proteincoupled receptor superfamily regulates multiple properties of the b2-adrenergic receptor. Biochemistry 1995 34 15407-15414. (doi:10.1021/bi00047a003).
Wess J, Nanavati S, Vogel Z & Maggio R. Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studied by mutational analysis of them3 muscarinic receptor. EMBO Journal 1993 12 331-338.
Lu ZL, Saldanha JW & Hulme EC. Transmembrane domains 4 and 7 of the M(1) muscarinic acetylcholine receptor are critical for ligand binding and the receptor activation switch. Journal of Biological Chemistry 2001 276 34098-34104. (doi:10.1074/jbc.M104217200).
